Min Sagong
Welcome,         Profile    Billing    Logout  
 5 Trials 
4 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Sagong, Min
PROUD, NCT05666804: Study Assessing the Efficacy and Safety of a Personalized Monotherapy Regimen of Brolucizumab in Patients With Symptomatic Macular Polypoidal Choroidal Vasculopathy

Recruiting
3
160
RoW
Brolucizumab 6mg, Beovu
Novartis Pharmaceuticals
Macular Polypoidal Choroidal Vasculopathy (PCV)
09/25
09/25
NCT06116916: Study to Assess the Efficacy & Safety of KHK4951 in Patients With Diabetic Macular Edema

Recruiting
2
150
Japan, US, RoW
KHK4951, Aflibercept Injection
Kyowa Kirin, Inc.
Diabetic Macular Edema (DME)
11/25
12/25
NCT06116890: Study to Assess the Efficacy & Safety of KHK4951 in Patients With Neovascular Age-Related Macular Degeneration

Recruiting
2
180
Japan, US, RoW
KHK4951, Aflibercept Injection
Kyowa Kirin, Inc.
Neovascular Age-Related Macular Degeneration (nAMD)
11/25
12/25
NCT05953012: Study to Assess Safety and Tolerability of PMC-403 in Subjects With Neovascular Age-related Macular Degeneration

Recruiting
1
36
RoW
PMC-403, Monotherapy
PharmAbcine, C&R Research, Inc.
Neovascular Age-related Macular Degeneration
05/24
10/25

Download Options